# Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer

> **NCT06321484** · PHASE1 · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 18 (estimated)

## Conditions studied

- Platinum-resistant Ovarian Cancer
- Recurrent Ovary Cancer
- Ovarian Cancer
- Ovarian Carcinoma
- Ovarian Carcinoma, Recurrent
- Endometroid Ovarian Carcinoma
- Clear Cell Ovarian Carcinoma

## Interventions

- **BIOLOGICAL:** Cytokine-Induced Memory-like Natural Killer Cells
- **DRUG:** Interleukin 2

## Key facts

- **NCT ID:** NCT06321484
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-09
- **Primary completion:** 2026-11-30
- **Final completion:** 2031-10-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06321484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06321484, "Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06321484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*